Cite
Functional Variant of Manganese Superoxide Dismutase (SOD2 V16A) Polymorphism Is Associated with Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Study.
MLA
Daehee Kang, et al. “Functional Variant of Manganese Superoxide Dismutase (SOD2 V16A) Polymorphism Is Associated with Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Study.” Cancer Epidemiology, Biomarkers & Prevention, vol. 16, no. 8, Aug. 2007, pp. 1581–86. EBSCOhost, https://doi.org/10.1158/1055-9965.EPI-07-0160.
APA
Daehee Kang, Kyoung-Mu Lee, Sue Kyung Park, Berndt, S. I., Peters, U., Reding, D., Chatterjee, N., Welch, R., Chanock, S., Wen-Yi Huang, & Hayes, R. B. (2007). Functional Variant of Manganese Superoxide Dismutase (SOD2 V16A) Polymorphism Is Associated with Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Study. Cancer Epidemiology, Biomarkers & Prevention, 16(8), 1581–1586. https://doi.org/10.1158/1055-9965.EPI-07-0160
Chicago
Daehee Kang, Kyoung-Mu Lee, Sue Kyung Park, Sonja I. Berndt, Ulrike Peters, Douglas Reding, Nilanjan Chatterjee, et al. 2007. “Functional Variant of Manganese Superoxide Dismutase (SOD2 V16A) Polymorphism Is Associated with Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Study.” Cancer Epidemiology, Biomarkers & Prevention 16 (8): 1581–86. doi:10.1158/1055-9965.EPI-07-0160.